Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue

Fertility and Sterility

Volumn 88, Issue 4 SUPPL., 2007, Pages 1029-1038

  Fechner, Sabine ^a   Husen, Bettina ^b   Thole, Hubert ^b   Schmidt, Markus ^a   Gashaw, Isabella ^a   Kimmig, Rainer ^a   Winterhager, Elke ^a   Grümmer, Ruth ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

17 HSD; Aromatase; aromatase; endometriosis; estrogen metabolism; nude mouse; STS

Indexed keywords

AROMATASE; DANAZOL; DYDROGESTERONE; ESTROGEN; FINROZOLE; MEDROXYPROGESTERONE ACETATE; STEROID RECEPTOR; STERYL SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEAL CAVITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CHORISTOMA; ENDOMETRIOSIS; ENDOMETRIUM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, NUDE;

EID: 34848860441     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.153     Document Type: Article

References (36)

1. Giudice L.C., and Kao L.C. Endometriosis. Lancet 364 (2004) 1789-1799
2. Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-425
3. Kitawaki J., Kado N., Ishihara H., Koshiba H., Kitaoka Y., and Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83 (2002) 149-155
4. Dizerega G.S., Barber D.L., and Hodgen G.D. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 33 (1980) 649-653
5. Thomas E.J. Endometriosis, 1995-confusion or sense?. Int J Gynaecol Obstet 48 (1995) 149-155
6. Wheeler J.M., Knittle J.D., and Miller J.D. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group. Am J Obstet Gynecol 169 (1993) 26-33
7. Waller K.G., and Shaw R.W. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 59 (1993) 511-515
8. Rice V.M. Conventional medical therapies for endometriosis. Ann NY Acad Sci 955 (2002) 343-352 discussion 389-93, 396-406
9. Zeitoun K.M., and Bulun S.E. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 72 (1999) 961-969
10. Bulun S.E., Economos K., Miller D., and Simpson E.R. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 79 (1994) 1831-1834
11. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83 (1998) 4474-4480
12. Bulun S.E., Zeitoun K., Takayama K., Noble L., Michael D., Simpson E., et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 6 (1999) 293-301
13. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J Clin Endocrinol Metab 81 (1996) 174-179
14. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 57 (1997) 514-519
15. Takayama K., Zeitoun K., Gunby R.T., Sasano H., Carr B.R., and Bulun S.E. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 69 (1998) 709-713
16. Grümmer R., Schwarzer F., Bainczyk K., Hess-Stumpp H., Regidor P.A., Schindler A.E., et al. Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod 16 (2001) 1736-1743
17. Zamah N.M., Dodson M.G., Stephens L.C., Buttram Jr. V.C., Besch P.K., and Kaufman R.H. Transplantation of normal and ectopic human endometrial tissue into athymic nude mice. Am J Obstet Gynecol 149 (1984) 591-597
18. Nisolle M., Casanas-Roux F., Marbaix E., Jadoul P., and Donnez J. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod 15 (2000) 572-577
19. Bruner-Tran K.L., Eisenberg E., Yeaman G.R., Anderson T.A., McBean J., and Osteen K.G. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 87 (2002) 4782-4791
20. Hull M.L., Charnock-Jones D.S., Chan C.L., Bruner-Tran K.L., Osteen K.G., Tom B.D., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88 (2003) 2889-2899
21. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 122 (1975) 262-263
22. Grummer R. Animal models in endometriosis research. Hum Reprod Update 12 (2006) 641-649
23. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F., and Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99 (1997) 2851-2857
24. Telimaa S., Puolakka J., Ronnberg L., and Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1 (1987) 13-23
25. Overton C.E., Lindsay P.C., Johal B., Collins S.A., Siddle N.C., Shaw R.W., et al. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 62 (1994) 701-707
26. Urabe M., Yamamoto T., Kitawaki J., Honjo H., and Okada H. Estrogen biosynthesis in human uterine adenomyosis. Acta Endocrinol (Copenh) 121 (1989) 259-264
27. Yamamoto T., Shiroshita K., Kitawaki J., and Okada H. The inductive effects of progestogens on aromatase activity in stromal cells of human uterine endometrium. J Endocrinol Invest 12 (1989) 201-204
28. Purohit A., Lai L.C., Singh A., Coldham N.G., Ghilchik M.W., Reed M.J., et al. The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours. J Steroid Biochem 34 (1989) 443-446
29. Thompson Jr. E.A., and Siiteri P.K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 249 (1974) 5373-5378
30. Fatemi H.M., Al-Turki H.A., Papanikolaou E.G., Kosmas L., De Sutter P., and Devroey P. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online 11 (2005) 455-457
31. Shippen E.R., and West Jr. W.J. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril 81 (2004) 1395-1398
32. Fang Z., Yang S., Gurates B., Tamura M., Simpson E., Evans D., et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab 87 (2002) 3460-3466
33. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15 (1994) 342-355
34. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C., El-Alfy M., et al. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 25 (2000) 1-16
35. Penning T.M. Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum Reprod Update 9 (2003) 193-205
36. Harris H.A., Bruner-Tran K.L., Zhang X., Osteen K.G., and Lyttle C.R. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 20 (2005) 936-941